Search Results
Showing 10 from 51 results
What are Biologics and Biosimilars
We explain the difference between biologics and biosimilars and showcase Teva s innovative work in this space
Biosimilars are advancing more treatment options for patients
Cory Wohlbach is responsible for steering Teva s new biosimilar products through the regulatory approval process He explains what biosimilars are how they have the potential to reduce costs for patients and how patient safety is always a top priority